The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.
about
Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implicationsBeyond fast food and slow motion: weighty contributors to the obesity epidemicComorbidities in Cushing's diseaseThe Treatment of Cushing's Disease.Is 11beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure.The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people.A direct comparison of quality of life in obese and Cushing's syndrome patients.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.Neuropsychiatric disorders in Cushing's syndromeEnvironmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis.A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause.Severe psychosis due to Cushing's syndrome in a patient with a carcinoid tumour in the lung: a case report and review of the current management.Mental Fatigue and Executive Dysfunction in Patients with Cushing's Syndrome in Remission.Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5.Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineGlucocorticoids and type 2 diabetes: from physiology to pathologyPredictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients.Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.Endocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism?Quality of life and other outcomes in children treated for Cushing syndrome.A case of incidentally discovered subclinical cushing syndrome in a patient with chronic fatigue and anxiety.Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.Characterization of persistent and recurrent Cushing's diseaseClinical consequences of Cushing's syndrome.Mifepristone: is there a place in the treatment of Cushing's disease?Psychiatric symptoms as a clinical presentation of Cushing's syndrome.Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function.Personality characteristics and quality of life in patients treated for Cushing's syndrome.Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors--a longitudinal study of 106 patients.Evaluation of depression, quality of life and body image in patients with Cushing's disease.The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.Are patients with pituitary adenomas at an increased risk of mental disorders?Psychological aspects of endocrine disease.A Study on Psychiatric Disorders, Body Image Disturbances, and Self-Esteem in Patients of Cushing's DiseasePersistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
P2860
Q24656111-004303FB-24AB-402F-B7F2-2FF7D38BE7AFQ27001046-3BE53AD2-6F18-4DE9-A73E-E043D0C31BE3Q27010491-2C908F66-A4A8-44E6-B531-4B879BD10A5FQ27010590-DC973838-353B-4517-8613-1628866E649EQ33693734-CCA03693-C814-4F20-958E-2880D5201336Q33720516-CC4E376B-702E-4FE6-9D71-C8205D0A4615Q34069860-2BAF8DC2-70D1-4909-B957-33814208EE93Q34279017-37B55D40-5DFA-4492-9777-05F07A4DD776Q35158376-2E1A1A96-C374-472B-9362-A2AB199F53BCQ35277899-BB163279-E940-4C02-BB47-E5B99A25689DQ35487292-868906E5-5A5C-4DA0-BA24-FAF11B47D51CQ35597599-C0C5F11D-C0F7-48CF-8020-57F93B56641DQ35634150-851B44BD-3F60-4CFD-875C-26FA46218629Q35668088-27E7A668-56DB-4BDB-BA92-C28EC284A036Q35843170-B89110D8-FA24-4AB4-BEBC-F8AB59EAAC61Q35892447-A83C92D6-3659-4032-A6D2-C0D4762A9DDFQ35916555-D2371FF5-30B5-4B95-A6D0-75FD414A8E87Q36506631-5FB5A527-0D4D-46CB-8FB0-85E9D392FDA9Q36663084-D67A20B2-2F68-4565-A108-C9619755D322Q36738333-2594ED03-BBF6-4420-8192-17CE8AB9918AQ36940053-FD26C099-A1A6-4485-9E50-24E00A3590EBQ36981968-9555C401-A5CD-4CE6-9F2D-9C52A15AD517Q37054178-419A5FF4-C376-4C8E-BDBB-76B283BE24BBQ37370170-24D30ED6-A0A4-4A05-86E6-3D4A94F610B8Q37610803-3F2BBC83-7E69-4BFB-8CF6-2F68AAD5C4C7Q38004913-8A262051-70D6-4E95-9B1D-5C8D3BA0B9C1Q38063404-EA89E2F8-2457-47A2-8F50-1A8CD35FF3A5Q42090979-5F7DBFF5-A0B1-4A36-A02C-41D4E4F474FAQ42164474-9268FD2E-5A9B-449A-AC18-BE5FD70F1C6AQ46951305-7DC3EEC4-9107-4783-9F22-5007F522DFC0Q48210650-EDF8FB51-3DEE-42C1-BCBF-5616ED197ABAQ48395926-B5958390-5D07-428F-AD6F-A5665324F60CQ48621132-0E3EDA19-2B6E-4208-8675-811C3BB34AD8Q51950827-E1161015-9F18-49FF-B202-4E34704F6795Q51990099-B030BEDF-65FD-4850-82DE-E05896287C8CQ56529496-87F9DB75-2DFC-4366-9B2C-154729D7F57EQ59043920-5DE45866-0EA0-497A-BC2F-92C90BFD3BFF
P2860
The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The longitudinal course of psy ...... orrection of hypercortisolism.
@en
The longitudinal course of psy ...... orrection of hypercortisolism.
@nl
type
label
The longitudinal course of psy ...... orrection of hypercortisolism.
@en
The longitudinal course of psy ...... orrection of hypercortisolism.
@nl
prefLabel
The longitudinal course of psy ...... orrection of hypercortisolism.
@en
The longitudinal course of psy ...... orrection of hypercortisolism.
@nl
P2093
P356
P1476
The longitudinal course of psy ...... orrection of hypercortisolism.
@en
P2093
P304
P356
10.1210/JC.82.3.912
P407
P577
1997-03-01T00:00:00Z